Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.360
+0.010 (0.43%)
At close: Apr 17, 2026, 4:00 PM EDT
2.368
+0.008 (0.33%)
After-hours: Apr 17, 2026, 5:44 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Avenue
1.40M----
Journey
61.86M56.13M79.18M--
Journey Growth
10.20%-29.11%---
Checkpoint
-41.00K103.00K--
Checkpoint Growth
--60.19%---
Fortress
-1.50M5.23M--
Fortress Growth
--71.31%---
Dermatology Products Sales
---73.67M63.13M
Dermatology Products Sales Growth
---16.69%41.78%
Pharmaceutical and Biotechnology Product Development
---2.07M5.66M
Pharmaceutical and Biotechnology Product Development Growth
----63.34%429.68%
Total
63.26M57.68M84.51M75.74M68.79M
Total Growth
9.69%-31.76%11.58%10.11%50.86%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States of America
63.26M57.68M84.51M75.74M68.79M
United States of America Growth
9.69%-31.76%11.58%10.11%50.86%
Total
63.26M57.68M84.51M75.74M68.79M
Total Growth
9.69%-31.76%11.58%10.11%50.86%
Source: S&P Global Market Intelligence.